EC Approves Additional Indication for Roche's Tecentriq in Lung Cancer Treatment

Retrieved on: 2021-05-07 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

EC Approves Additional Indication for Roche's Tecentriq in Lung Cancer Treatment. View article details on hiswai:

Excerpt

Roche announced on May 5, 2021 that the European Commission (EC) has approved Tecentriq (atezolizumab) as a first-line treatment for metastatic ...

Article found on: www.biopharminternational.com